Evidence map›Paper›PMID 42089682›Full record

ArticleAmerican journal of respiratory and critical care medicine2026

Role of casual contact in drug-resistant tuberculosis transmission: a molecular epidemiology study.

Neel R Gandhi, Kogieleum Naidoo, Keeren Lutchminarain, Shaheed V Omar, Hikari Yoshii, Fay Willis, Resha Boodhram, Thabisile Gwala, Angela Campbell, Megan M Coe and 18 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Neel R GandhiDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.ORCID 0000-0002-1665-299X
Kogieleum NaidooCAPRISA-MRC HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.ORCID 0000-0002-8874-6661
Keeren LutchminarainDepartment of Medical Microbiology, School of Laboratory Medicine and Medical Science, University of KwaZulu Natal; Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Shaheed V OmarCentre for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Hikari YoshiiDepartment of Pediatrics, School of Medicine, Emory University, Atlanta, GA, United States.
Fay WillisDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Resha BoodhramCAPRISA-MRC HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Thabisile GwalaCentre for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Angela CampbellDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Megan M CoeDepartment of Global Health, University of Washington, Seattle, WA, United States.
A Nichole EvansDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Linrui TangDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.ORCID 0000-0003-0144-0019
Melanie H ChitwoodDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.
Senzo R HlathiCAPRISA-MRC HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Patience N MbathaCAPRISA-MRC HIV/TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Lavania JosephCentre for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Hermina Van Der MeulenCentre for Tuberculosis, National and WHO Supranational TB Reference Laboratory, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Koleka MlisanaDepartment of Medical Microbiology, School of Laboratory Medicine and Medical Science, University of KwaZulu Natal; Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Samuel M JennessDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.ORCID 0000-0001-8840-105X
Mark N LurieDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI, United States.
Barry N KreiswirthCenter for Discovery and Innovation, Hackensack Meridien Health, Nutley, NJ, United States.
Joshua L WarrenDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, United States.
Kristin N NelsonDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
Sara C AuldDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.ORCID 0000-0002-8972-3736
James C M BrustDepartment of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, United States.
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States.ORCID 0000-0002-8091-7198
Barun MathemaDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
N Sarita ShahDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi, Jyothi Rengarajan · 2022 to 2026
$5.8M
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network StudyR01AI138646 · NIAID · EMORY UNIVERSITY · PI NAIDOO, KOGIELEUM, SHAH, NIPPIE SARITA · 2018 to 2022
$3.8M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
Mentoring of multidisciplinary global health research in tuberculosis and HIVK24AI155045 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BRUST, JAMES C M · 2020 to 2025
$889k
Mentoring Multidisciplinary Patient-Oriented Research in TB, HIV, and Global HealthK24AI165099 · NIAID · EMORY UNIVERSITY · PI Nippie Sarita Shah · 2023 to 2026
$781k
Emory/Georgia Tuberculosis Research Advancement Center P30AI168386Emory University Center for AIDS Research P30AI050409National Institute of Allergy and Infectious DiseasesNIAID NIH HHS K24 AI165099NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI138646NIH HHS K23AI166093NIH HHS K24AI114444NIH HHS K24AI155045NIH HHS K24AI165099NIH HHS R01AI138646
6 · The paper itself

Abstract

rationaleTransmission is the primary driver of tuberculosis (TB) and drug-resistant TB (DR-TB) in high-burden countries; however, where and between whom spread occurs is poorly understood.

objectivesWe conducted universal whole genome sequencing (WGS) to evaluate the role of casual contact in Mycobacterium tuberculosis transmission.

methodsWe recruited persons diagnosed with second-line DR-TB (eg, extensively drug-resistant [XDR], pre-XDR-TB) from June 2018 to December 2022 in metropolitan Durban, South Africa. We collected named contacts and GPS coordinates of homes, clinics, and community locations visited regularly before diagnosis. Among participants genotypically clustered by whole genome sequencing (≤12 single-nucleotide polymorphisms), we quantified the proportion attributable to close versus casual contact. Close contact was defined as person-to-person links or overlapping hospitalizations. Casual contact links were based on geographic proximity of homes and community locations, or shared outpatient clinics. MEASUREMENTS AND MAIN

resultsWe enrolled 305 of 383 (80%) persons diagnosed with second-line DR-TB. TB isolates were sequenced for 251 (83%) participants; 141 (56%) were genotypically linked, forming 25 clusters (range, 2-49 persons/cluster). Among clustered participants, 69 (49%) were epidemiologically linked by casual contact and 13 (9%) through close contact. Multivariable analysis identified living within 1 km (OR, 17.9), visiting proximate community locations (OR, 1.88), shared outpatient clinic (OR, 1.72), and person-to-person links (OR, 5.38) as significant risk factors associated with genotypic clustering.

conclusionsCasual contact in community locations accounted for half of transmission among genotypic clusters in a high-burden setting. Efforts to curb TB will require a greater emphasis on community-based measures to identify cases from casual contact or undetected intermediate cases, in addition to the current mainstay of contact tracing.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdultContact TracingFemaleGenotypeHumansMaleMiddle AgedMolecular EpidemiologySouth AfricaWhole Genome SequencingYoung Adultdrug resistancetransmissiontuberculosiswhole genome sequencing

Identifiers

PMID42089682
PMCPMC13318217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.